(Q49068786)

18 February 2018

title

In vivo characteristics of dopamine D2 receptor occupancy by amisulpride in schizophrenia (English)

1 reference

18 February 2018

Marie-Laure Paillère Martinot

0 references

0 references

2

object named as

M L Paillère-Martinot

1 reference

18 February 2018

author name string

J L Martinot

1

1 reference

18 February 2018

M F Poirier

3

1 reference

18 February 2018

M H Dao-Castellana

4

1 reference

18 February 2018

C Loc'h

5

1 reference

18 February 2018

B Mazière

6

1 reference

18 February 2018

publication date

1 March 1996

1 reference

18 February 2018

published in

Psychopharmacology

1 reference

18 February 2018

volume

124

1 reference

18 February 2018

issue

1-2

1 reference

18 February 2018

page(s)

154-158

1 reference

18 February 2018

Loss of striatal [76Br]bromospiperone binding sites demonstrated by positron tomography in progressive supranuclear palsy

cites work

1 reference

https://api.crossref.org/works/10.1007%2FBF02245616

Kinetic analysis of central [76Br]bromolisuride binding to dopamine D2 receptors studied by PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02245616

Central D2-dopamine receptor occupancy in schizophrenic patients treated with antipsychotic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02245616

Positron emission tomographic analysis of central D1 and D2 dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine. Relation to extrapyramidal side effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02245616

Dopamine blockade and clinical response: evidence for two biological subgroups of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02245616

Amisulpride versus haloperidol in treatment of schizophrenic patients--results of a double-blind study

21 January 2018

1 reference

12 December 2020

[76Br]bromolisuride: a new tool for quantitative in vivo imaging of D-2 dopamine receptors

1 reference

12 December 2020

Dopamine Receptor Binding Predicts Clinical and Pharmacological Potencies of Antischizophrenic Drugs

1 reference

12 December 2020

3H-spiperone binding sites in post-mortem brains from schizophrenic patients: Relationship to neuroleptic drug treatment, abnormal movements, and positive symptoms

1 reference

12 December 2020

The estimated density of D2 striatal receptors in schizophrenia. A study with positron emission tomography and 76Br-bromolisuride

1 reference

12 December 2020

In vivo assay for neuroleptic receptor binding in the striatum. Positron tomography in humans

1 reference

12 December 2020

Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics

1 reference

12 December 2020

Central D2-dopamine receptor occupancy in relation to antipsychotic drug effects: a double-blind PET study of schizophrenic patients

1 reference

12 December 2020

Antischizophrenic drugs: chronic treatment elevates dopamine receptor binding in brain

1 reference

12 December 2020

Behavioral deficits induced by low doses of apomorphine in rats: evidence for a motivational and cognitive dysfunction which discriminates among neuroleptic drugs.

1 reference

12 December 2020

Potentiation by low doses of selected neuroleptics of food-induced conditioned place preference in rats.

1 reference

12 December 2020

Treatment of positive and negative symptoms: pharmacologic approaches

1 reference

12 December 2020

Benzamides and classical neuroleptics: Comparison of their actions using 6 apomorphine-induced effects

1 reference

12 December 2020

In vivo quantitative imaging of dopamine receptors in human brain using positron emission tomography and [76Br]bromospiperone

1 reference

12 December 2020

Striatal dopamine receptor occupancy during and following withdrawal from neuroleptic treatment: correlative evaluation by positron emission tomography and plasma prolactin levels

1 reference

12 December 2020

Improvement of some schizophrenic deficit symptoms with low doses of amisulpride

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF02245616

1 reference

18 February 2018

Dimensions Publication ID

1046000716

0 references

1 reference

18 February 2018